This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07441/identifier/chemspider/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07441/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07441/identifier/pubchem-compound/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07441/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07441/identifier/drugbank/
n9http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07441
rdf:type
n8:Drug
n8:group
experimental
owl:sameAs
n4:DB07441 n14:DB07441
dcterms:title
3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID
adms:identifier
n6:394184 n7:DB07441 n11:99443912 n12:BC1 n13:446965
n8:IUPAC-Name
n9:271B4497-363D-11E5-9242-09173F13E4C5
n8:InChI
n9:271B449D-363D-11E5-9242-09173F13E4C5
n8:Molecular-Formula
n9:271B449C-363D-11E5-9242-09173F13E4C5
n8:Molecular-Weight
n9:271B4499-363D-11E5-9242-09173F13E4C5
n8:Monoisotopic-Weight
n9:271B449A-363D-11E5-9242-09173F13E4C5
n8:SMILES
n9:271B449B-363D-11E5-9242-09173F13E4C5
n8:Water-Solubility
n9:271B4495-363D-11E5-9242-09173F13E4C5
n8:logP
n9:271B4493-363D-11E5-9242-09173F13E4C5 n9:271B4496-363D-11E5-9242-09173F13E4C5
n8:logS
n9:271B4494-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Acceptor-Count
n9:271B44A3-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Donor-Count
n9:271B44A4-363D-11E5-9242-09173F13E4C5
n8:InChIKey
n9:271B449E-363D-11E5-9242-09173F13E4C5
n8:Polar-Surface-Area--PSA-
n9:271B449F-363D-11E5-9242-09173F13E4C5
n8:Polarizability
n9:271B44A1-363D-11E5-9242-09173F13E4C5
n8:Refractivity
n9:271B44A0-363D-11E5-9242-09173F13E4C5
n8:Rotatable-Bond-Count
n9:271B44A2-363D-11E5-9242-09173F13E4C5
n8:Bioavailability
n9:271B44A9-363D-11E5-9242-09173F13E4C5
n8:Ghose-Filter
n9:271B44AB-363D-11E5-9242-09173F13E4C5
n8:MDDR-Like-Rule
n9:271B44AC-363D-11E5-9242-09173F13E4C5
n8:Number-of-Rings
n9:271B44A8-363D-11E5-9242-09173F13E4C5
n8:Physiological-Charge
n9:271B44A7-363D-11E5-9242-09173F13E4C5
n8:Rule-of-Five
n9:271B44AA-363D-11E5-9242-09173F13E4C5
n8:Traditional-IUPAC-Name
n9:271B4498-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-acidic-
n9:271B44A5-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-basic-
n9:271B44A6-363D-11E5-9242-09173F13E4C5